Genotype-Phenotype Correlations in a Group of 15 SCN1A-Mutated Italian Patients with GEFS+ Spectrum (Seizures plus,Classical and Borderline Severe Myoclonic Epilepsy of Infancy)
Restricted accessOtherFirst published online November, 2010
Genotype-Phenotype Correlations in a Group of 15 SCN1A-Mutated Italian Patients with GEFS+ Spectrum (Seizures plus,Classical and Borderline Severe Myoclonic Epilepsy of Infancy)
Mutations in SCN1A gene have been associated with the spectrum of generalized/genetic epilepsy with febrile seizures plus. Recently, databases reporting SCN1A mutations and clinical details of patients have been created to facilitate genotype— phenotype correlations, actually not completely defined, particularly if a specific mutation underlies phenotypes. We report on a group of 15 patients with clinical features of GEFS+ (3), classical (7), or borderline severe myoclonic epilepsy of infancy (5), in whom genetic analysis of patients and parents and follow-up period were performed to establish genotype—phenotype correlations, to enrich literature and databases data. We found 11 pathogenic mutations (5 novel: c.80 G>C exon 1; c.187 T>C exon 1; c.3061 G>T exon 16; c.4297 G>A exon 22; c.5579 delA ins TCTCC exon 26) and 4 novel nucleotidic variants (IVS5+38 C>T intron 5; IVS8-19 C>T intron 18; c.4945 C>T exon 25; c.5127 C>A exon 26). Paternal inheritance was observed in 4/4 cases.
Scheffer IE, Berkovic SFGeneralized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain. 1997;120(pt 3):479-490.
2.
Scheffer IE, Zhang YH, Jansen FE, et al. Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus? Brain Dev. 2009;31:394-400.
3.
Singh R., Andermann E., Whitehouse WP, et al. Severe myoclonic epilepsy of infancy: extended spectrum of GEFS+ ? Epilepsia. 2001;42:837-844.
4.
Dravet C.Les épilepsies graves de l’enfant. Vie Med. 1978;8: 543-548.
5.
Scheffer IE, Harkin LA, Dibbens LM, et al. Neonatal epilepsy syndromes and generalized epilepsy with febrile seizures plus (GEFS+). Epilepsia. 2005;46(Suppl 10):41-47.
6.
Wolff M., Cassè-Perrot C., Dravet C.Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia. 2006 ;47(Suppl. 2):45-48.
7.
Fujiwara T., Sugawara T., Mazaki-Miyazaki E., et al. Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures . Brain. 2003.126(pt 3):531-546.
8.
Fukuma G., Oguni H., Shirasaka Y., et al. Mutations of neuronal voltage-gated Na+ channel alpha 1 subunit gene SCN1A in core severe myoclonic epilepsy in infancy (SMEI) and in borderline SMEI (SMEB). Epilepsia. 2004.45:140-148.
9.
Gambardella A., Marini C.Clinical spectrum of SCN1A mutations. Epilepsia.2009;50(Suppl 5):20-23.
10.
Stafstrom CESevere epilepsy syndromes of early childhood: the link between genetics and pathophysiology with a focus on SCN1A mutations . J Child Neurol.2009;24(Suppl): 15S-23S.
Claes LR, Deprez L., Suls A., et al. The SCN1A variant database: a novel research and diagnostic tool. Hum Mutat. 2009;30:E904-E920.
13.
Kalume F., Yu FH, Westenbroek RE, et al. Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy. J Neurosci.2007;27:11065-11074.
14.
Lossin C., Rhodes TH, Desai RR, et al. Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A. J Neurosci. 2003;23:11289-11295.
15.
Ohmori I., Kahlig KM, Rhodes TH, et al. Nonfunctional SCN1A is common in severe myoclonic epilepsy of infancy. Epilepsia. 2006;47:1636-1642.
16.
Kanai K., Hirose S., Oguni H., et al. Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity. Neurology. 2004;27:63:329-334.
17.
Kanai K., Yoshida S., Hirose S., et al. Physicochemical property changes of amino acid residues that accompany missense mutations in SCN1A affect epilepsy phenotype severity. J Med Genet. 2009;46:671-679.
18.
Wallace RH, Scheffer IE, Parasivam G., et al. Generalized epilepsy with febrile seizures plus: mutation of the sodium channel subunit SCN1B. Neurology. 2002;58:1426-1429.
19.
Baulac S., Huberfeld G., Gourfinkel-An I., et al. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet. 2001;28:46-48.
20.
Malacarne M. , Madia F., Gennaro E., et al. Lack of SCN1A mutations in familial febrile seizures. Epilepsia. 2002;43:559-562.
21.
Wang JW, Kurahashi H., Ishii A., et al. Microchromosomal deletions involving SCN1A and adjacent genes in severe myoclonic epilepsy in infancy. Epilepsia. 2008;49:1528-1534.
22.
Striano P., Mancardi MM, Biancheri R., et al. Brain MRI findings in severe myoclonic epilepsy in infancy and genotype-phenotype correlations. Epilepsia. 2007;48:1092-1096.
Heron SE, Scheffer IE, Iona X., et al. De novo SCN1A mutations in Dravet syndrome and related epileptic encephalopathies are largely of paternal origin. J Med Genet . 20010;47:137-141.
Osaka H., Ogiwara I., Mazaki E., et al. Patients with a sodium channel alpha 1 gene mutation show wide phenotypic variation. Epilepsy Res. 2007;75:46-51.
27.
Madia F., Striano P., Gennaro E., et al. Cryptic chromosome deletions involving SCN1A in severe myoclonic epilepsy of infancy. Neurology. 2006;67:1230-1235.
28.
Kimura K., Sugawara T., Mazaki-Miyazaki E., et al. A missense mutation in SCN1A in brothers with severe myoclonic epilepsy in infancy (SMEI) inherited from a father with febrile seizures. 2005. Brain Dev. 27:424-430.
29.
Weiss LA, Escayg A., Kearney JA, et al. Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Mol Psychiatry. 2003;8:186-194.
30.
Meisler MH, Kearney JASodium channel mutations in epilepsy and other neurological disorders. J Clin Invest. 2005; 115:2010-2017.
31.
Iannetti P., Parisi P., Spalice A., et al. Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy. Epilepsy Res. 2009;85:89-95.
32.
Depienne C., Arzimanoglou A., Trouillard O., et al. Hum Parental mosaicism can cause recurrent transmission of SCN1A mutations associated with severe myoclonic epilepsy of infancy. Hum Mutat. 2006;27:389.
33.
Morimoto M. , Mazaki E., Nishimura A., et al. SCN1A mutation mosaicism in a family with severe myoclonic epilepsy in infancy. Epilepsia. 2006;47:1732-1736.
34.
Gennaro E., Santorelli FM, Bertini E., et al. Somatic and germline mosaicisms in severe myoclonic epilepsy of infancy. Biochem Biophys Res Commun. 2006 ;10;341:489-493.
35.
Marini C., Mei D., Helen Cross J., et al. Mosaic SCN1A mutation in familial severe myoclonic epilepsy of infancy. Epilepsia. 2006; 47:1737-1740.
36.
Marini C., Scheffer IE, Nabbout R., et al. SCN1A duplications and deletions detected in Dravet syndrome: implications for molecular diagnosis. Epilepsia. 2009 [Epub ahead of print].
37.
Selmer KK, Eriksson AS, Brandal K., et al. Parental SCN1A mutation mosaicism in familial Dravet syndrome . Clin Genet. 2009;76: 398-403.
38.
Miyama S., Goto T., Inoue Y., et al. Monozygotic twins with severe myoclonic epilepsy in infancy discordant for clinical features. Pediatr Neurol. 2008;39:120-122.
39.
Mancardi MM , Striano P., Gennaro E., et al. Familial occurrence of febrile seizures and epilepsy in severe myoclonic epilepsy of infancy (SMEI) patients with SCN1A mutations. Epilepsia. 2006;47(10):1629-1635.
40.
Claes L., Del-Favero J., Ceulemans B., et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet. 2001;68(6):1327-1332.
41.
Sugawara T. , Mazaki-Miyazaki E., Fukushima K., et al. Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology. 2002;58(7):1122-1124.
42.
Oguni H., Hayashi K., Osawa M., et al. Severe myoclonic epilepsy in infancy: clinical analysis and relation to SCN1A mutations in a Japanese cohort. Adv Neurol . 2005;95:103-117.
